Yuval Cohen, Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 10,500 shares at $0.25 ($3K) on 2022-05-16, disclosed to the SEC on 2022-05-16.
Seasonal purchase ($3k) by Chief Executive Officer — this insider has traded CRBP in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| CRBP | SELL | 2025-10-27 | $942K | — | Filing → |
| CRBP | SELL | 2025-02-18 | $125K | — | Filing → |
| CRBP | SELL | 2024-06-18 | $5.9M | — | Filing → |